Application of botulinum toxin to the management of neurogenic inflammatory disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 16, 2000
Grant Date -
N/A
app pub date -
Sep 4, 1997
filing date -
Sep 4, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a method for the use of at least one serotype or a combination of serotypes of Botulinum neurotoxin either alone or in combination with other peptides or fusion proteins, that when administered in a safe and effective amount, antagonize and therefore decrease or block inflammation induced by the neurogenic mechanisms underlying or associated with inflammatory disorders, in particular, arthritis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully